Global Furosemide Market Insights and Forecast to 2028

SKU ID : QYR- 20040749

Publishing Date : 27-Jan-2022

No. of pages : 95

PRICE
4900
7350
9800

  • Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
    Market Analysis and Insights: Global Furosemide Market
    Due to the COVID-19 pandemic, the global Furosemide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Injection accounting for % of the Furosemide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
    China Furosemide market size is valued at US$ million in 2021, while the US and Europe Furosemide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Furosemide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
    The global key manufacturers of Furosemide include Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
    Global Furosemide Scope and Segment
    Furosemide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Furosemide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
    Segment by Type
    Injection
    Solution
    Tablet
    Segment by Application
    Hospital
    Pharmacy
    Clinics
    Others
    By Company
    Sanofi Aventis
    US Pharm Holdings
    Mylan
    Sandoz
    Hospira
    West-Ward Pharms
    Ivax Sub Teva Pharms
    Emcure Pharms
    Sun Pharm Inds
    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports